Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma
Clinical trial NCT00290511 · COMPLETED
Trial details
- NCT number
- NCT00290511
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-29
- Primary completion
- 2021-02-12
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.